Research
Hormonal
Preconception weight optimization in women with obesity is important to reduce maternal and fetal risks.
Practitioners should prioritize weight management in women with obesity planning for pregnancy.
StrongSupportsmedium confidence
Current clinical guidelines emphasize the importance of preconception weight optimization in women with obesity to reduce maternal and fetal risks.
Why this rating
Based on the authoritative nature of clinical guidelines mentioned.
Source
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment
Andrijana Koceva et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 2025
DOI 10.1016/j.beem.2025.102038
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →